A First Human Study of a Ferroportin Antibody

Clinical trial NCT01330953 · COMPLETED

Trial details

NCT number: NCT01330953
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2011-03-01
Primary completion: 2011-09-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.